Stay updated on COVID-AIV for Respiratory Failure Clinical Trial
Sign up to get notified when there's something new on the COVID-AIV for Respiratory Failure Clinical Trial page.

Latest updates to the COVID-AIV for Respiratory Failure Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoChange DetectedDifference0.8%
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new version of a clinical trial for the treatment of Critical COVID-19 with respiratory failure, including changes in trial design and details about the investigational drug Aviptadil. The previous version's detailed descriptions of the drug's mechanism and trial outcomes have been significantly reduced.SummaryDifference33%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.8%
- Check59 days agoChange DetectedDifference0.7%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to COVID-AIV for Respiratory Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COVID-AIV for Respiratory Failure Clinical Trial page.